{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:08:44Z","timestamp":1788952124566,"version":"build-2803163510"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.4103\/ijd.ijd_6_25","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T13:02:39Z","timestamp":1756904559000},"page":"380-382","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Successful Treatment of Refractory Pityriasis Lichenoides Chronica with Upadacitinib in Two Patients"],"prefix":"10.4103","volume":"70","author":[{"given":"Xueting","family":"Zeng","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, Fuzhou, Fujian, China"},{"name":"Fujian Dermatology and Venereology Research Institute, Fuzhou, Fujian, China"},{"name":"Central Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zequn","family":"Tong","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Fuzhou, Fujian, China"},{"name":"Fujian Dermatology and Venereology Research Institute, Fuzhou, Fujian, China"},{"name":"Central Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchen","family":"Huang","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Fuzhou, Fujian, China"},{"name":"Fujian Dermatology and Venereology Research Institute, Fuzhou, Fujian, China"},{"name":"Central Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbei","family":"Bao","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Fuzhou, Fujian, China"},{"name":"Fujian Dermatology and Venereology Research Institute, Fuzhou, Fujian, China"},{"name":"Central Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gong","sequence":"additional","affiliation":[{"name":"Key Laboratory of Skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, China E-mail: gongtingfy@fjmu.edu.cn, jichaofy@fjmu.edu.cn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ji","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Fuzhou, Fujian, China"},{"name":"Fujian Dermatology and Venereology Research Institute, Fuzhou, Fujian, China"},{"name":"Central Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"R1-20251031","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2005.07.058","article-title":"Pityriasis lichenoides and its subtypes","volume":"55","author":"Bowers","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R2-20251031","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamadermatol.2021.4047","article-title":"Evaluation and treatment of febrile ulceronecrotic mucha-habermann disease with ruxolitinib and tocilizumab as guided by cytokine profile","volume":"157","author":"Wu","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R3-20251031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Commun Signal CCS"},{"key":"R4-20251031","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","article-title":"Trial of upadacitinib and adalimumab for psoriatic arthritis","volume":"384","author":"McInnes","year":"2021","journal-title":"N Engl J Med"},{"key":"R5-20251031","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s13555-022-00842-7","article-title":"Safety and efficacy of upadacitinib for atopic dermatitis in Japan: 2-year interim results from the phase 3 rising up study","volume":"13","author":"Katoh","year":"2023","journal-title":"Dermatol Ther"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_6_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:29:46Z","timestamp":1787837386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_6_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_6_25","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-01-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}